Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Expected to Be in 2029?

The market for the synthesis and manufacturing of messenger ribonucleic acid (mRNA) has seen a quick expansion in the recent times. The market is projected to surge from a value of $4.56 billion in 2024 to hit $5.14 billion in 2025, documenting a compound annual growth rate (CAGR) of 12.7%. The historic growth in the market can be linked to factors such as an increase in government funds allocated for pandemic readiness, the preliminary triumph of COVID-19 mRNA vaccines, a budding interest in personalized medicine, a rising occurrence of infectious illnesses, and cooperative efforts between academic institutions and biotechnology entities.

Over the coming years, a swift expansion is anticipated in the market size of messenger ribonucleic acid (mRNA) synthesis and manufacturing. The market is predicted to reach $8.21 billion in 2029, with a compound annual growth rate (CAGR) of 12.5%. This growth in the projected period could be as a result of the broadening of therapeutic uses beyond just vaccines, technological progress in mRNA delivery mechanisms, augmented investment in the infrastructure of biomanufacturing, increasing demand for swift vaccine production platforms, and enhanced support from regulatory bodies for expedited approvals. Significant trends projected in the forecast period consist of the movement towards decentralized and modular mRNA manufacturing units, the incorporation of AI and automation into synthesis workflows, the creation of heat-stable mRNA formulations, the emergence of circRNA technology, and the advent of self-amplifying mRNA platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp

What Are The Contributors To Demand In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?

The continuing rise of infectious diseases is anticipated to boost the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in the future. Infectious diseases are disorders triggered by disease causing microorganisms such as bacteria, viruses, fungi, or parasites, inclusive of diseases like malaria which spread both directly or indirectly. This rise of infectious diseases is the result of rapid urbanization, contributing to increased population density and close human contact – factors that aid the transmission of infections. mRNA synthesis and manufacturing are crucial in fighting infectious diseases, by facilitating the quick development and scalable production of specifically targeted vaccines and therapeutic drugs that provoke a particular immune response. For example, in November 2023, the World Health Organization reported that there were approximately 249 million malaria cases (an infectious disease) worldwide in 2022, experiencing an increase of 5 million cases (2%) compared to 2021. Therefore, it’s the escalating prevalence of infectious diseases that is driving the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.

What Segmentation Categories Are Included In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Analysis?

The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –

1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis

2) By Scale Of Operation: Preclinical, Clinical, Commercial

3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas

4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications

Subsegments:

1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services

2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services

What Upcoming Trends Are Expected To Impact The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Globally?

Leading businesses in the messenger ribonucleic acid (mRNA) synthesis and manufacturing industry are focusing on the creation of novel products like co-transcriptional capping platforms in order to expedite preclinical research and decrease regulatory obstacles. Co-transcriptional capping platform is a proprietary approach that successfully adds a defensive cap to mRNA molecules during synthesis process, thereby improving the stability, translation efficiency, and control of immunogenicity of mRNA. For example, in May 2025, GenScript, an American life sciences research tools firm, introduced its good manufacturing practice (GMP)-equivalent mRNA production service. Developed to produce high-quality, functional mRNA for preclinical studies that facilitate new drug applications, including toxicology, biodistribution, and pharmacokinetics or pharmacodynamics evaluations, this service is scalable and aware of regulatory requirements. Established in cleanroom-compliant, ISO 7-classified environments, this service utilizes patented co-transcriptional capping technology and delivers tailor-made mRNA in around seven weeks. This ground-breaking development bridges the crucial gap between research-grade and complete GMP manufacturing and lets early-stage biotechnology and pharmaceutical firms carry out studies that meet regulatory standards without the expense and delay of traditional GMP production.

Who Are The Top-Ranked Companies In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Today?

Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-and-manufacturing-global-market-report

How Is Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25832&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model